AP39 suppresses osteoclast differentiation and neural factor expression under inflammatory condition. [PDF]
Li P, Wang S, Lv Y, Wang Y.
europepmc +1 more source
Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation. [PDF]
Schrenk S +4 more
europepmc +1 more source
Interaction Between Glucagon-like Peptide 1 and Its Analogs with Amyloid-β Peptide Affects Its Fibrillation and Cytotoxicity. [PDF]
Litus EA +12 more
europepmc +1 more source
GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review. [PDF]
Saad Alfaiz A.
europepmc +1 more source
Correlation in the change of gut microbiota with clinical periodontal parameters in grade C periodontitis patients after non-surgical periodontal therapy. [PDF]
Mutafcilar Velioglu E +5 more
europepmc +1 more source
Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review. [PDF]
Afshari S +7 more
europepmc +1 more source
Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs. [PDF]
Gao H +7 more
europepmc +1 more source
Heterogeneous and evolving epitope landscape of clinical anti-drug antibodies against multidomain biotherapeutic: a case study of TAK-186. [PDF]
Sun R +5 more
europepmc +1 more source
ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India - An Update (2025). [PDF]
Madhu SV +4 more
europepmc +1 more source
GLP1 receptor agonism alters growth and therapeutic response in prostate cancer. [PDF]
Bera S +8 more
europepmc +1 more source

